Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$3.15

0.15 (5.00%)

16:20
11/18/16
11/18
16:20
11/18/16
16:20

Immunomedics confirms venBio's submitted notice of board director nominations

Immunomedics confirmed that venBio Select Advisor LLC has submitted a notice of nomination of four director candidates to stand for election to the Immunomedics board of directors at the company's 2016 Annual Meeting of Stockholders to be held on December 14, 2016. The company issued the following statement: "The Immunomedics Board of Directors and management team are committed to acting in the best interests of the company and all stockholders and regularly seeks qualified candidates for the Board. To that end, while venBio did not engage in discussions with the company prior to nominating a majority slate for election to the Board just four weeks prior to the upcoming 2016 Annual Meeting, Immunomedics' Governance and Nominating Committee will consider venBio's director candidates and respond in due course. Immunomedics has achieved a number of important milestones in 2016, including delivering positive Phase 2 clinical trial results of IMMU-132 in patients with metastatic triple-negative breast cancer, which have been submitted for publication; achieving our timetable for the manufacturing of clinical materials for the Phase 3 confirmatory trial in TNBC; and nearing completion of enrolling 100 patients into our ongoing open-label Phase 2 trial by year-end 2016. The company has also retained Greenhill & Co. to pursue licensing and other strategic activities with regard to preclinical and clinical pipeline products as well as platform technologies. The company is at a pivotal point in its growth trajectory as it prepares to submit an accelerated approval application to the FDA for IMMU-132 in mid-2017 and believes disruption in its strategy at this time could destroy value and potentially disrupt the company's clinical trial activities for late-stage cancer patients. Additionally, as previously announced, at the annual meeting of the American Society of Hematology in December 2016, the company will premiere a new antibody-drug conjugate known as IMMU-140 and the company anticipates delivering interim results for IMMU-132 at a symposium on genitourinary cancers to be held in early 2017. Immunomedics is well-positioned to execute on the company's strategy, drive innovation in the targeted treatment of cancer, autoimmune disorders and other serious diseases and enhance stockholder value, and perhaps most importantly help patients suffering from cancer."

IMMU Immunomedics
$3.15

0.15 (5.00%)

05/06/16
JEFF
05/06/16
UPGRADE
Target $5
JEFF
Buy
Immunomedics upgraded to Buy from Hold at Jefferies
Jefferies analyst Chris Howerton upgraded Immunomedics to Buy saying IMMU-132 continues to demonstrate impressive clinical data in solid tumors. The analyst sees a greater likelihood of Immunomedics securing a partner for the asset following recent data. He raised his price target for the shares to $5.00 from $1.50.
06/21/16
WELS
06/21/16
DOWNGRADE
WELS
Market Perform
Immunomedics downgraded to Market Perform from Outperform at Wells Fargo
10/06/16
JEFF
10/06/16
INITIATION
Target $5.5
JEFF
Buy
Immunomedics assumed with a Buy at Jefferies
Jefferies analyst Matthew Andrews assumed coverage of Immunomedics with a Buy rating and raised his price target for the shares to $5.50 from $5. IMMU-132's "promising results" in Triple Negative breast cancer sets the stage for a partnership deal in the coming months, Andrews tells investors in a research note.
10/18/16
JEFF
10/18/16
NO CHANGE
JEFF
Jefferies sees 'attractive buying opportunities' in Biotech
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. While volatility will likely continue into the election, valuation multiples are near-historic lows and policy concerns, while valid, are likely overstated, the analysts tell investors in a research note. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment. Jefferies likes Gilead (GILD) and Celgene (CELG) among large-caps, The Medicines Co. (MDCO), Alkermes (ALKS) and Vertex (VRTX) among mid-caps, and Alder Biopharmaceuticals (ALDR), Cempra (CEMP), Ultragenyx (RARE) and Immunomedics (IMMU) among small-caps.

TODAY'S FREE FLY STORIES

JD

JD.com

$43.08

0.13 (0.30%)

10:10
06/27/17
06/27
10:10
06/27/17
10:10
Options
Closing buyer in JD.com Jan 40 strike puts »

Closing buyer in JD.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPPGY

WPP PLC

$105.93

0.11 (0.10%)

10:07
06/27/17
06/27
10:07
06/27/17
10:07
Periodicals
WPP affected by cyber attack, Reuters reports »

Reuters cites a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNRO

Monro Muffler

$45.95

1.2 (2.68%)

, AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

10:04
06/27/17
06/27
10:04
06/27/17
10:04
Recommendations
Monro Muffler, Amazon.com analyst commentary  »

Stephens sees Monro…

MNRO

Monro Muffler

$45.95

1.2 (2.68%)

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

10:03
06/27/17
06/27
10:03
06/27/17
10:03
General news
Consumer Confidence data reported »

June Consumer Confidence…

OIH

Oil Services Holders Trust

$24.35

-0.02 (-0.08%)

10:00
06/27/17
06/27
10:00
06/27/17
10:00
Options
VanEck Vectors Oil Services ETF with notable option action »

VanEck Vectors Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
06/27/17
06/27
10:00
06/27/17
10:00
General news
U.S. Consumer Confidence Preview: »

U.S. Consumer Confidence…

COST

Costco

$160.20

3.07 (1.95%)

09:59
06/27/17
06/27
09:59
06/27/17
09:59
Conference/Events
Costco management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 23

    Aug

AA

Alcoa

$31.97

0.79 (2.53%)

09:57
06/27/17
06/27
09:57
06/27/17
09:57
Recommendations
Alcoa analyst commentary  »

Alcoa price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$70.16

-0.83 (-1.17%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Kellogg put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$103.16

3.41 (3.42%)

, DRI

Darden

$92.62

2.54 (2.82%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Early notable gainers among liquid option names on June 27th »

Notable gainers among…

CCI

Crown Castle

$103.16

3.41 (3.42%)

DRI

Darden

$92.62

2.54 (2.82%)

KSS

Kohl's

$38.27

0.75 (2.00%)

M

Macy's

$22.76

0.2944 (1.31%)

AMT

American Tower

$135.11

2.65 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

  • 21

    Sep

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

, CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Financial Services Committee to hold a hearing Nasdaq CBOE Holdings Charles Schwab »

The Capital Markets,…

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

SCHW

Charles Schwab

$42.35

0.5 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 26

    Jul

CME

CME Group

$123.65

-0.47 (-0.38%)

, CS

Credit Suisse

$14.23

0.26 (1.86%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Agriculture Committee to hold a hearing »

The Committee holds a…

CME

CME Group

$123.65

-0.47 (-0.38%)

CS

Credit Suisse

$14.23

0.26 (1.86%)

ICE

IntercontinentalExchange

$64.59

0.24 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 01

    Aug

KW

Kennedy Wilson

09:54
06/27/17
06/27
09:54
06/27/17
09:54
Conference/Events
Kennedy Wilson management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

IRBT

iRobot

$100.98

-0.22 (-0.22%)

09:52
06/27/17
06/27
09:52
06/27/17
09:52
Periodicals
iRobot mentioned cautiously by Spruce Point Capital 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$46.40

-0.15 (-0.32%)

09:51
06/27/17
06/27
09:51
06/27/17
09:51
Conference/Events
IHS Markit management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

ALNY

Alnylam

$82.92

-2.29 (-2.69%)

09:50
06/27/17
06/27
09:50
06/27/17
09:50
Conference/Events
Alnylam participates in a conference call with Piper Jaffray »

Piper Jaffray Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

APDN

Applied DNA Sciences

$1.40

0.31 (28.44%)

09:49
06/27/17
06/27
09:49
06/27/17
09:49
Hot Stocks
Applied DNA Sciences signs new licensing agreement with Himatsingka America »

Applied DNA Sciences is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPC

Pilgrim's Pride

$22.40

-0.44 (-1.93%)

09:45
06/27/17
06/27
09:45
06/27/17
09:45
Periodicals
Humane Society issues report making allegations on Pilgrim's Pride supply chain 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

PFE

Pfizer

09:42
06/27/17
06/27
09:42
06/27/17
09:42
Hot Stocks
Pfizer expects to hire additional 80 employees for R&D facility in coming years »

Pfizer (PFE) broke ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 02

    Aug

  • 27

    Aug

KSS

Kohl's

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Kohls calls lead puts 50:1 in early chatter-driven flow »

Kohls calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$35.09

0.98 (2.87%)

, OIH

Oil Services Holders Trust

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Unusually active option classes on open June 27th »

Unusual total active…

VIAB

Viacom

$35.09

0.98 (2.87%)

OIH

Oil Services Holders Trust

MDLZ

Mondelez

CLF

Cliffs Natural

RAD

Rite Aid

WDC

Western Digital

$92.66

-0.68 (-0.73%)

S

Sprint

KO

Coca-Cola

GM

General Motors

SLV

iShares Silver Trust

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 03

    Aug

  • 16

    Nov

NWS

News Corp

$14.10

0.05 (0.36%)

, NWSA

News Corp.

$13.66

0.07 (0.52%)

09:39
06/27/17
06/27
09:39
06/27/17
09:39
Hot Stocks
News Corp 'applauds' European Commission's decision to fine Google »

The following statement…

NWS

News Corp

$14.10

0.05 (0.36%)

NWSA

News Corp.

$13.66

0.07 (0.52%)

GOOG

Alphabet

$952.27

-13.32 (-1.38%)

GOOGL

Alphabet Class A

$972.09

-14 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

BAP

Credicorp

09:35
06/27/17
06/27
09:35
06/27/17
09:35
Downgrade
Credicorp rating change  »

Credicorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.